These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19637088)

  • 1. Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
    Gupta NK; Barker JN; Young JW; Noy A
    Leuk Lymphoma; 2009 Dec; 50(12):2075-7. PubMed ID: 19637088
    [No Abstract]   [Full Text] [Related]  

  • 2. Comeback for the camptothecins?
    Kirschbaum M
    Leuk Lymphoma; 2009 Dec; 50(12):1914-5. PubMed ID: 19860622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].
    Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S; Hirose Y; Umehara H
    Rinsho Ketsueki; 2005 Sep; 46(9):1074-7. PubMed ID: 16440768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
    Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
    Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital.
    Innocenti F; Undevia SD; Ramírez J; Mani S; Schilsky RL; Vogelzang NJ; Prado M; Ratain MJ
    Clin Pharmacol Ther; 2004 Nov; 76(5):490-502. PubMed ID: 15536463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy?
    Nabhan C; Mehta J
    Leuk Lymphoma; 2012 Oct; 53(10):1859-66. PubMed ID: 22448919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
    Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide induced remission of refractory diffuse large B-Cell Lymphoma post-allogeneic SCT.
    Tueger S; Chen FE; Ahsan G; McDonald V; Andrews VE; Madrigal JA; Kazmi MA
    Haematologica; 2006 Jun; 91(6 Suppl):ECR16. PubMed ID: 16785122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
    Mounier N; Canals C; Gisselbrecht C; Cornelissen J; Foa R; Conde E; Maertens J; Attal M; Rambaldi A; Crawley C; Luan JJ; Brune M; Wittnebel S; Cook G; van Imhoff GW; Pfreundschuh M; Sureda A;
    Biol Blood Marrow Transplant; 2012 May; 18(5):788-93. PubMed ID: 22005647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
    Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case report.
    Wu P; Ma T; Chen Y; Wang F; Chen Y; Gao J; Zhou Z; Jia Y
    Anticancer Drugs; 2021 Sep; 32(8):886-889. PubMed ID: 34145178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Patients With Histologic Transformation.
    Reddy NM
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S100-S104. PubMed ID: 28760294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
    Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T
    Bone Marrow Transplant; 2008 Mar; 41(6):591-3. PubMed ID: 18071292
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic cell transplantation for lymphomas.
    Ayala E; Tomblyn M
    Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of front-line autologous transplant in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma.
    Holtan SG; Feldman AL; Knudson RA; Ketterling RP; Porrata LF
    Bone Marrow Transplant; 2011 Jun; 46(6):904-5. PubMed ID: 20818450
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
    Desai AA; Kindler HL; Taber D; Agamah E; Mani S; Wade-Oliver K; Ratain MJ; Vokes EE
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):421-6. PubMed ID: 15895230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation for diffuse large B cell lymphoma: defining the role of allografts.
    Uhm J; Kuruvilla J
    Transfus Apher Sci; 2013 Aug; 49(1):63-71. PubMed ID: 23790650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.